MetaCap

Boston Scientific (BSX) vs 3M (MMM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

3M (MMM) has outperformed Boston Scientific (BSX) over the past year, gaining 5.9% versus a loss of 56.7%. Over five years, MMM leads with a +21.3% price change compared with +8.8% for BSX. 3M is the larger company by market cap ($91.97 billion vs $60.85 billion), about 1.5 times the size, while Boston Scientific is growing revenue faster (+19.9% vs +1.5%).

On valuation, Boston Scientific trades at a lower forward P/E (13.4x vs 17.9x for 3M). 3M pays a dividend yielding 1.72%, while Boston Scientific does not currently pay one. Boston Scientific converts more of its revenue into profit, with a net margin of 14.4% versus 13.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BSX-56.67%MMM+5.89%
+19%-21%-61%
Nov 21, 20251 yearNov 20, 2026
BSX+2.32%MMM+18.77%
+172%+55%-62%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BSX versus MMM key metrics
MetricBSXMMM
Share price$41.98$177.99
Market cap$60.85B$91.97B
1-day change-2.35%-0.27%
YTD return-55.97%+11.17%
1-year return-56.67%+5.89%
5-year return+8.84%+21.28%
P/E ratio (TTM)17.7126.57
Forward P/E13.4117.94
EPS (TTM)$2.37$6.70
Dividend yield0.00%1.72%
Annual dividend$0.00$3.07
Revenue (latest FY)$20.07B$24.95B
Revenue growth (YoY)+19.87%+1.52%
Net income (latest FY)$2.89B$3.25B
Gross margin69.01%39.91%
Operating margin18.00%18.55%
Net margin14.41%13.03%
52-week high$101.91$196.90
52-week low$39.57$139.34
Distance from 52-week high-58.81%-9.60%
Analyst consensusbuybuy
Avg. price target upside+18.15%+9.00%
Average volume19.19M3.28M
Shares outstanding1.45B516.73M
Employees59,00060,500
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • MMM has outperformed BSX by 62.6 percentage points over the past year.
  • 3M trades at a higher earnings multiple (26.6x vs 17.7x trailing P/E).
  • 3M offers a meaningfully higher dividend yield (1.72% vs 0.00%).
  • Boston Scientific grew revenue faster in its latest fiscal year (+19.87% vs +1.52%).

About Boston Scientific

BSX stock →

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.

Health Care · Medical/Dental Instruments · 59,000 employees

About 3M

MMM stock →

3M Company provides diversified technology services in the America, the Asia Pacific, Europe, the Middle East, Africa, and internationally. It operates through three segments: Safety and Industrial, Transportation and Electronics, and Consumer.

Health Care · Medical/Dental Instruments · 60,500 employees

BSX vs MMM FAQ

Which is bigger, Boston Scientific or 3M?

3M (MMM) is larger, with a market capitalization of $91.97B compared with $60.85B for Boston Scientific (BSX).

Which stock has performed better over the past year, BSX or MMM?

MMM returned +5.89% over the past 12 months, compared with -56.67% for BSX (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, BSX or MMM?

BSX has the lower trailing P/E at 17.7, versus 26.6 for MMM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Boston Scientific or 3M?

3M pays a dividend yielding 1.72%, while Boston Scientific does not currently pay a regular dividend.

Are Boston Scientific and 3M in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons